BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 20533066)

  • 1. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders.
    Kaneko Y; Miyajima H; Piperno A; Tomosugi N; Hayashi H; Morotomi N; Tsuchida K; Ikeda T; Ishikawa A; Ota Y; Wakusawa S; Yoshioka K; Kono S; Pelucchi S; Hattori A; Tatsumi Y; Okada T; Yamagishi M
    J Gastroenterol; 2010 Nov; 45(11):1163-71. PubMed ID: 20533066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological study of Japanese patients with genetic iron overload syndromes.
    Hattori A; Miyajima H; Tomosugi N; Tatsumi Y; Hayashi H; Wakusawa S
    Pathol Int; 2012 Sep; 62(9):612-8. PubMed ID: 22924847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-HFE hepatic iron overload.
    Pietrangelo A; Caleffi A; Corradini E
    Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
    Girelli D; Trombini P; Busti F; Campostrini N; Sandri M; Pelucchi S; Westerman M; Ganz T; Nemeth E; Piperno A; Camaschella C
    Haematologica; 2011 Apr; 96(4):500-6. PubMed ID: 21173098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients.
    Santos PC; Cançado RD; Pereira AC; Schettert IT; Soares RA; Pagliusi RA; Hirata RD; Hirata MH; Teixeira AC; Figueiredo MS; Chiattone CS; Krieger JE; Guerra-Shinohara EM
    Blood Cells Mol Dis; 2011 Apr; 46(4):302-7. PubMed ID: 21411349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; Eckfeldt JH; McLaren CE; Reiss JA; McLaren GD; Reboussin DM; Gordeuk VR; Speechley MR; Press RD; Dawkins FW;
    Am J Hematol; 2008 Feb; 83(2):126-32. PubMed ID: 17726683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload.
    Biasiotto G; Belloli S; Ruggeri G; Zanella I; Gerardi G; Corrado M; Gobbi E; Albertini A; Arosio P
    Clin Chem; 2003 Dec; 49(12):1981-8. PubMed ID: 14633868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes.
    Mendes AI; Ferro A; Martins R; Picanço I; Gomes S; Cerqueira R; Correia M; Nunes AR; Esteves J; Fleming R; Faustino P
    Ann Hematol; 2009 Mar; 88(3):229-34. PubMed ID: 18762941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepcidin in iron overload disorders.
    Papanikolaou G; Tzilianos M; Christakis JI; Bogdanos D; Tsimirika K; MacFarlane J; Goldberg YP; Sakellaropoulos N; Ganz T; Nemeth E
    Blood; 2005 May; 105(10):4103-5. PubMed ID: 15671438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis.
    Hattori A; Tomosugi N; Tatsumi Y; Suzuki A; Hayashi K; Katano Y; Inagaki Y; Ishikawa T; Hayashi H; Goto H; Wakusawa S
    Blood Cells Mol Dis; 2012 Mar; 48(3):179-82. PubMed ID: 22297252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload.
    Barisani D; Pelucchi S; Mariani R; Galimberti S; Trombini P; Fumagalli D; Meneveri R; Nemeth E; Ganz T; Piperno A
    J Hepatol; 2008 Jul; 49(1):123-33. PubMed ID: 18462824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of hereditary hemochromatosis.
    Liu J; Pu C; Lang L; Qiao L; Abdullahi MA; Jiang C
    Histol Histopathol; 2016 Aug; 31(8):833-40. PubMed ID: 27031690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
    Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary iron overload].
    Brissot P; Bardou-Jacquet E; Latournerie M; Ropert-Bouchet M; Island ML; Loréal O; Jouanolle AM
    Pathol Biol (Paris); 2010 Oct; 58(5):316-23. PubMed ID: 19942367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload.
    Badar S; Busti F; Ferrarini A; Xumerle L; Bozzini P; Capelli P; Pozzi-Mucelli R; Campostrini N; De Matteis G; Marin Vargas S; Giorgetti A; Delledonne M; Olivieri O; Girelli D
    Am J Hematol; 2016 Jun; 91(4):420-5. PubMed ID: 26799139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
    Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
    Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.